Evaluation of prescribing patterns in diabetic and hypertensive patients in a South Delhi Hospital

Vikas Pandey, Ubedul Hoda, M. Aqil, M. Sharma, M. Akhtar, R. Khandelwal, Abul Kalam Najmi


Background: Drug utilization studies (DUS) defined by World Health Organization as the marketing, distribution, prescription and use of drugs in a society, considering its consequences, either medical, social, and economic. The increasing importance of DUS as a valuable investigation resource in pharmacoepidemiology has been linking it with other health related areas, such as public health, pharmacovigilance, pharmacoeconomics, and pharmacogenetics.

Methods: The study was a prospective DUS carried out in medicine OPD of Indian Institute of Technology Hospital, New Delhi, India in which a total of 595 prescriptions of hypertensive and diabetic patients were reviewed. All diabetic and/or hypertensive patients; irrespective of age, gender; who had least one drug in the prescription were included. Data were collected by screening of physician’s prescribing record and patient medication profile.

Results: A total of 595 prescriptions were recorded. 57.31% were males as compared to 42.69% females. 54.62% patients were hypertensive (325 prescription); 14.78% patients were diabetic (88 prescription) whilst 30.58% had both the diseases. Of 507 prescriptions having antihypertensive drugs, combination therapy was utilized (40.8%) in the prescriptions and out of 270 prescriptions having antidiabetic drugs, 143 (52.96%) prescription were of combination therapy. Among antihypertensive drugs, angiotensin-converting enzyme inhibitors were the most frequently prescribed class of drugs (19.18%). The combination most commonly prescribed was amlodipine and atenolol (14.05%). Antidiabetic drugs made up for 11.05% of the total drugs prescribed. 28.78% of all hypoglycemic agents were sulfonylurea. Glimepiride and metformincombination was the most prescribed anti-diabetic drugs combination (16.16%).

Conclusion: Both hypertension and diabetes are considered to be lifestyle diseases. Hence, apart from optimal and appropriate prescribing, there is a need for lifestyle modification to obtain improved outcomes. Combination therapy was observed in a high percentage of prescriptions. Though monotherapy is associated with improved compliance and fewer side effects, combination therapy is desirable for synergistic actions and to overcome complications.


Drug utilization study, Anti-hypertensive, Anti-diabetic

Full Text:



WHO Expert Commitee. The Selection of Essential Drugs, Technical Report Series no.615. Geneva: World Health Organization; 1977.

Available from: http://www.who.int/topics/diabetes_mellitus. [Last accessed on 2006 May 07].

Mayor S. Diabetes affecting nearly 250 million adults in the world. Br Med J. 2006;333:1191.

Martin K. The twin killers: diabetes + obesity. AJP 2001;82:522-3.

King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-31.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.

Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827-38.

Hansson L. The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension. J Hypertens. 1996;14:537-44.

Nissinen A, Böthig S, Granroth H, Lopez AD. Hypertension in developing countries. World Health Stat Q. 1988;41(3-4):141-54.

Hansson L, Dahlöf B, Gudbrandsson T, Hellsing T, Kullman S, Kuylenstierna J, et al. Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy. J Cardiovasc Pharmacol. 1988;12:94-101.

Kjeldsen SE, Farsang C, Sleigh P, Mancia G, World Health Organization, International Society of Hypertension. 1999 WHO/ISH hypertension guidelines – Highlights and esh update. J Hypertens. 2001;19(12):2285-8.

Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, et al. British Hypertension Society guidelines for hypertension management 1999: Summary. BMJ. 1999;319(7210):630-5.

Kapoor B, Raina RK, Kapoor S. Drug prescribing pattern in a teaching hospital. Indian J Pharmacol. 1985;17 Suppl 1:168.

Pradhan SC, Shewade DG, Shashindran CH, Bapna JS. Drug utilization studies. Natl Med J India. 1988;1:185.

Cidda M, Mateti UV, Batchu MK, Martha S. Study of prescribing patterns of antihypertensives in South Indian population. Int J Basic Clin Pharmacol. 2014;3(2):303-7.

Ziesmer V, Ghosh S, Aronow WS. Use of antihypertensive drug therapy in older persons in an academic nursing home. J Am Med Dir Assoc. 2003;4 Suppl 2: S20-2.

Al Khaja KA, Sequeira RP, Mathur VS, Damanhori AH, Abdul Wahab AW. Family physicians’ and general practitioners’ approaches to drug management of diabetic hypertension in primary care. J Eval Clin Pract. 2002;8(1):19-30.

Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. Circulation. 2006;113(2):213-21.

Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J. 2004;45(3):117-20.

Al Khaja KA, Sequeira RP, Mathur VS. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain. Ann Pharmacother. 2001;35(11):1350-9.

Lau GS, Chan JC, Chu PL, Tse DC, Critchely JA. Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong. Ann Pharmacother. 1996;30(3):232-7.